A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory Glioma
Clinical trial NCT07599371 · RECRUITING
Trial details
- NCT number
- NCT07599371
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2027-10-10
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.